X0306 4 2017-02-10 0 0000885306 CYNOSURE INC CYNO 0001345975 Davin Michael R C/O CYNOSURE, INC. 5 CARLISLE ROAD WESTFORD MA 01886 1 1 0 0 Chairman, President and CEO Class A Common Stock 2017-02-10 4 M 0 8438 0.00 A 32562 D Class A Common Stock 2017-02-13 4 F 0 4319 50.8816 D 28243 D Class A Common Stock 2017-02-11 4 M 0 11088 0.00 A 39331 D Class A Common Stock 2017-02-13 4 F 0 5670 50.9447 D 33661 D Class A Common Stock 2017-02-13 4 M 0 7881 0.00 A 41542 D Class A Common Stock 2017-02-14 4 F 0 2917 65.8791 D 38625 D Restricted Stock Units 2017-02-10 4 M 0 8438 0.00 D Class A Common Stock 8438 16875 D Restricted Stock Units 2017-02-11 4 M 0 11088 0.00 D Class A Common Stock 11088 11088 D Restricted Stock Units 2017-02-13 4 M 0 7881 0.00 D Class A Common Stock 7881 0 D On February 10, 2017, 8,438 shares that were acquired by the reporting person pursuant to the award of restricted stock units on February 10, 2016 vested and were paid to the reporting person. On February 13, 2017, 4,319 of these 8,438 shares were withheld and sold in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to pay the resulting tax liability. The sales price reported represents the weighted average sales price of shares sold in multiple transaction at prices ranging from $49.00 to $52.99 per share. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. On February 11, 2017, 11,088 shares that were acquired by the reporting person pursuant to the award of restricted stock units on February 11, 2015 vested and were paid to the reporting person. On February 13, 2017, 5,670 of these 11,088 shares were withheld and sold in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to pay the resulting tax liability. The sales price reported represents the weighted average sales price of shares sold in multiple transaction at prices ranging from $50.00 to $50.99 per share. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. On February 13, 2017, 7,881 shares that were acquired by the reporting person pursuant to the award of restricted stock units on February 13, 2014 vested and were paid to the reporting person. On February 14, 2017, 2,917 of these 7,881 shares were withheld and sold in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to pay the resulting tax liability. The sales price reported represents the weighted average sales price of shares sold in multiple transaction at prices ranging from $65.00 to $65.99 per share. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. The restricted stock units are scheduled to vest as follows: 8,438 shares on February 10, 2018 and 8,437 shares on February 10, 2019. The restricted stock units are scheduled to vest as follows: 11,088 shares on February 11, 2018. The restricted stock units from the February 13, 2014 award are fully vested as of February 13, 2017. Christopher J. Geberth, Attorney-in-fact 2017-02-14